SIFI recibe opinión positiva del CHMP para AKANTIOR® (polihexanida 0,08%) en queratitis por acanthamoeba

Posted on by

ACI SANT’ANTONIO, Italia, 31 de mayo de 2024 /PRNewswire/ — SIFI anunció que el Comité de Medicamentos de Uso Humano (CHMP) de la Agencia Europea de Medicamentos (EMA) ha adoptado una opinión positiva recomendando la aprobación de AKANTIOR® (polihexanida con denominación común…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.